Q-omics provides the consensus-scored CT47A11 profile across patient tissues and cancer cell-line models. Additionally, CT47A11 RNA expression shows 36 significant mutation-linked associations, with the highest sampling consensus in SCLC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for CT47A11 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with CT47A11 in patient tissues and cancer cell lines. In patient samples, CT47A11 shows the broadest associations at the RNA and protein expression levels, with SCLC recurring as the lineage with the largest associated feature set. In cancer cell lines, CT47A11 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in CNS.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Mutation	36	SCLC (36)	view →
RNA	7	SCLC (7)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼Protein (mass-spec)
Drug	65	CNS (63)	view →